Mixed Epithelial Tumor of Ovary

Mixed Epithelial Tumor of Ovary, also known as ovarian mixed epithelial tumor, is related to transitional cell carcinoma and papillary cystadenocarcinoma. An important gene associated with Mixed Epithelial Tumor of Ovary is EPO (Erythropoietin), and among its related pathways/superpathways are MIF Mediated Glucocorticoid Regulation and Hematopoietic Stem Cells and Lineage-specific Markers. The drugs Bevacizumab and Endothelial Growth Factors have been mentioned in the context of this disorder. Affiliated tissues include ovary and endothelial, and related phenotype is Increased shRNA abundance (Z-score > 2).